CurveBeam AI Limited (ASX:CVB)

Australia flag Australia · Delayed Price · Currency is AUD
0.0590
+0.0020 (3.51%)
At close: Apr 28, 2026
-39.18%
Market Cap 28.19M
Revenue (ttm) 12.15M
Net Income (ttm) -16.17M
Shares Out 477.73M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 293,402
Average Volume 328,373
Open 0.0610
Previous Close 0.0570
Day's Range 0.0590 - 0.0610
52-Week Range 0.0450 - 0.1750
Beta 1.79
RSI 47.59
Earnings Date Apr 30, 2026

About CurveBeam AI

CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and Australia. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot and ankle; InReach, a point-of-care extremity CT imaging which assess the distal extremities with 3D clarity at a fraction of the dose; and CubeVue Sof... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2009
Employees 50
Stock Exchange Australian Securities Exchange
Ticker Symbol CVB
Full Company Profile

Financial Performance

In fiscal year 2025, CurveBeam AI's revenue was 12.10 million, an increase of 85.33% compared to the previous year's 6.53 million. Losses were -16.84 million, -27.09% less than in 2024.

Financial Statements

News

There is no news available yet.